Correction
Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
Paper Information
Record ID:
50240
Author(s):
Journal:
Publication Date:
July 22, 2020
Retraction Date:
June 23, 2023
(2.4 years years ago)
Subjects:
Institutions:
Country:
🇯🇵 JapanArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Retraction Reasons:
Nature of Retraction:
Correction
Retraction Notice:
10.1186/s12885-023-11091-yAdditional Notes:
See also: https://pubpeer.com/publications/11C16030FE8525FCD1BD80511A06F3
Citations (25)
25
Total Citations5
Post-Retraction(20.0%)
19
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
529
Days since retraction (latest)
Iron regulates MT1-MMP-mediated proMMP-2 activation and cancer cell invasion
Risa Takatsuka, Minoru Terashima, Akihiko Ishimura et al. (5 authors)
Biochemical and Biophysical Research Communications
Open Access
Published: Dec 2024
529 days after retraction
Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells
Ji Min Park, Yen‐Hao Su, Chi-Shuan Fan et al. (15 authors)
Experimental & Molecular Medicine
Open Access
Published: Sep 2024
2 citations
2 citations
453 days after retraction
Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes
Benjamin N. Gantner, Flávio R. Palma, Madhura R. Pandkar et al. (8 authors)
Trends in cancer
Published: Sep 2024
6 citations
6 citations
449 days after retraction
Paper citing Invasion inhibition in pancreatic cancer using the...
Unknown Authors
Unknown Journal
Published: Jan 2024
211 days after retraction
Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway
Fu Wang, Weiqi Xu, Wanqin Zhang et al. (14 authors)
Hepatology International
Published: Nov 2023
10 citations
10 citations
150 days after retraction
Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
Shogo Amano, Seiji Kaino, Shuhei Shinoda et al. (10 authors)
BMC Cancer
Open Access
Published: Jun 2023
1 citation
1 citation
Same day as retraction
Targeting iron metabolism in osteosarcoma
Xiaowei Ma, Jiazheng Zhao, Helin Feng
Discover Oncology
Open Access
Published: Mar 2023
11 citations
11 citations
105 days before retraction
Engine shutdown: migrastatic strategies and prevention of metastases
Martina Raudenská, Kateřina Petrláková, Tamara Juriňáková et al. (9 authors)
Trends in cancer
Open Access
Published: Feb 2023
36 citations
36 citations
128 days before retraction
Plant-derived chelators and ionophores as potential therapeutics for metabolic diseases
Vanessa J. Lee, Samuel E. Janisse, Marie C. Heffern
Chemical Society Reviews
Published: Jan 2023
11 citations
11 citations
173 days before retraction
Repurposed Drugs in Gastric Cancer
Diana Araújo, Eduarda Ribeiro, Irina Amorim et al. (4 authors)
Molecules
Open Access
Published: Dec 2022
9 citations
9 citations
175 days before retraction
A DFX-based iron nanochelator for cancer therapy
Peng Liu, Qiang Wang, Kuan Li et al. (10 authors)
Frontiers in Bioengineering and Biotechnology
Open Access
Published: Nov 2022
3 citations
3 citations
207 days before retraction
Puzzling out iron complications in cancer drug resistance
Marjan Abedi, Soheila Rahgozar
Critical Reviews in Oncology/Hematology
Published: Jul 2022
6 citations
6 citations
328 days before retraction
Attenuation of tryptophan metabolism by Fe chelators: A hypothesis regarding inhibiting tumor suppressive microenvironments in pancreatic ductal adenocarcinoma
Egarit Noulsri, Surada Lerdwana
Medical Hypotheses
Published: Jun 2022
358 days before retraction
Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo
Nan Zhou, Yan Cui, Rui Zhu et al. (13 authors)
Gynecologic Oncology
Open Access
Published: Jun 2022
6 citations
6 citations
381 days before retraction
Iron Metabolism and Immune Regulation
Shuo Ni, Yin Yuan, Yanbin Kuang et al. (4 authors)
Frontiers in Immunology
Open Access
Published: Mar 2022
163 citations
163 citations
457 days before retraction
HSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy
Ke Liu, Jun Huang, Jiao Liu et al. (7 authors)
Cancer Research
Open Access
Published: Mar 2022
27 citations
27 citations
477 days before retraction
The Impact of Iron Chelators on the Biology of Cancer Stem Cells
Julia Szymonik, Kamila Wala, Tomasz Górnicki et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2021
33 citations
33 citations
548 days before retraction
Therapeutic potential of induced iron depletion using iron chelators in Covid-19
Punnoth Poonkuzhi Naseef, Muhammed Elayadeth‐Meethal, K.T. Mohammed Salim et al. (7 authors)
Saudi Journal of Biological Sciences
Open Access
Published: Dec 2021
22 citations
22 citations
557 days before retraction
Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia
Maura Argenziano, Chiara Tortora, Alessandra Di Paola et al. (8 authors)
Oncotarget
Open Access
Published: Jun 2021
8 citations
8 citations
731 days before retraction
6-Thioguanine bimolecular formation for dual chelation of iron: DFT study
Kun Harismah, Narjes Hajali, Hasan Zandi
Computational and Theoretical Chemistry
Published: May 2021
4 citations
4 citations
758 days before retraction
Collective Polarization of Cancer Cells at the Monolayer Boundary
Liu‐Yuan Guan, Jian-Qing Lv, Deqing Zhang et al. (4 authors)
Micromachines
Open Access
Published: Jan 2021
4 citations
4 citations
882 days before retraction
Crosstalk between Macrophages, T Cells, and Iron Metabolism in Tumor Microenvironment
Lesang Shen, Yunxiang Zhou, Haifei He et al. (9 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Jan 2021
69 citations
69 citations
903 days before retraction
Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulation of HDAC1 in molecular subtypes of breast cancer
Amjad Ali, Jasmin Shafarin, Hema Unnikannan et al. (8 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2021
24 citations
24 citations
903 days before retraction
Fabrication of deferasirox-decorated aptamer-targeted superparamagnetic iron oxide nanoparticles (SPION) as a therapeutic and magnetic resonance imaging agent in cancer therapy
Seyed Mojtaba Mashmoul Moghadam, Mona Alibolandi, Maryam Babaei et al. (6 authors)
JBIC Journal of Biological Inorganic Chemistry
Published: Nov 2020
21 citations
21 citations
959 days before retraction
Iron and Cancer: 2020 Vision
Suzy V. Torti, Frank M. Torti
Cancer Research
Open Access
Published: Sep 2020
141 citations
141 citations
1012 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #50241
Dec 11, 2023Quick Stats
Total Citations:
25
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025